Volitionrx (VNRX) Free Cash Flow (2011 - 2025)

Volitionrx has reported Free Cash Flow for 15 years, with the latest figure at -$5.5 million in Q4 2025.

• For the quarter ending Q4 2025, Free Cash Flow changed 0.03% year-over-year to -$5.5 million; the trailing twelve-month figure through Dec 2025 stood at -$19.8 million (up 24.45% YoY), and the FY2025 full-year result was -$19.8 million, up 24.45% from the prior year.
• Free Cash Flow for Q4 2025 stood at -$5.5 million, down from -$3.6 million in the prior quarter.
• The five-year high for Free Cash Flow was $7.2 million in Q4 2023, with the low at -$9.2 million in Q3 2023.
• Historically, Free Cash Flow has averaged -$5.1 million across 5 years, with a median of -$6.0 million in 2021.
• The largest YoY upside for Free Cash Flow was 213.17% in 2023 against a maximum downside of 350.87% in 2023.
• Volitionrx's Free Cash Flow stood at -$4.5 million in 2021, then plunged by 40.65% to -$6.4 million in 2022, then soared by 213.17% to $7.2 million in 2023, then plunged by 176.21% to -$5.5 million in 2024, then advanced by 0.03% to -$5.5 million in 2025.
• The last three Free Cash Flow figures came in at -$5.5 million (Q4 2025), -$3.6 million (Q3 2025), and -$6.3 million (Q2 2025), per Business Quant data.